Please login to the form below

Not currently logged in
Email:
Password:

regenerative medicine

This page shows the latest regenerative medicine news and features for those working in and with pharma, biotech and healthcare.

Ferring agrees Chinese reproductive medicine research deal

Ferring agrees Chinese reproductive medicine research deal

Ferring agrees Chinese reproductive medicine research deal. Work with the Chinese Academy of Sciences on the long-term project. ... CAS has an additional interest in the collaboration, as it will provide expertise and funding to support their stem cell

Latest news

  • Mallinckrodt pays $1.2bn for Sucampo Pharma Mallinckrodt pays $1.2bn for Sucampo Pharma

    The company snapped up Infacare for £425m earlier this year to claim a treatment for jaundice, added regenerative medicine firm Stratatech for an undisclosed sum last in 2016 and has also

  • A unique ecosystem A unique ecosystem

    Regenerative medicine aims to repair injuries or diseased organs using biomaterials, gene therapy, cell therapy and tissue engineering. ... It has an almost unlimited growth potential. The global market for regenerative medicine is estimated to reach

  • NICE backs Europe's first stem cell therapy NICE backs Europe's first stem cell therapy

    We are delighted that NICE has recommended that eligible patients have access to this personalised and regenerative medicine for a rare and seriously debilitating orphan condition," commented Chiesi's UK managing

  • Key role for French cluster in regenerative medicine project Key role for French cluster in regenerative medicine project

    Key role for French cluster in regenerative medicine project. Medicen Paris Region will be responsible for long-term impact of the BONE project. ... French life science cluster the Medicen Paris Region has been recruited to play a key role in a

  • Healthcare in the digital age Healthcare in the digital age

    One of the largest academic healthcare organisations in the Netherlands, in 2014 employing some 11, 000 people, UMC focuses on treating brain, infective and immunological conditions, regenerative medicine, children’s health,

More from news
Approximately 2 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • Health on instalment Health on instalment

    Express Scripts stands ready to do its part.”. Or as the Alliance for Regenerative Medicine’s co founder Michael Werner put it: “When you’ve got products that demonstrate the kind

  • A unique ecosystem A unique ecosystem

    Regenerative medicine aims to repair injuries or diseased organs using biomaterials, gene therapy, cell therapy and tissue engineering. ... It has an almost unlimited growth potential. The global market for regenerative medicine is estimated to reach

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    Commenters, including the Regenerative Medicine Experts Group in the UK, have suggested that the current Health Technology Assessment (HTA) methodologies, such as the National Institute for Health and Care Excellence (NICE), ... The NICE appraisal

  • Deal Watch July 2016 Deal Watch July 2016

    a privately held regenerative medicine company. ... Acquisition. 80. BioD/ Derma Sciences. Regenerative medicine productions derived from placental &birth tissues for multiple indications.

  • Deal Watch November 2015 Deal Watch November 2015

    Ocata operates in the field of regenerative medicine and is being acquired through Laurel Acquisition (a subsidiary of Astellas). ... 380. Ocata Therapeutics. Astellas Pharma| Laurel. Acquisition - company. Regenerative medicine pipeline focus on

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Emotive grows medical writing capacity Emotive grows medical writing capacity

    Prior to this she worked at the Swiss Institute for Regenerative Medicine as its project manager and scientific medical writer.

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Forte’s expertise is predominantly in regenerative medicine, cell therapy, medical and regulatory affairs industries and is currently chief commercialisation officer and chair of the commercialisation committee for the International Society

  • Avita Medical appoints CEO Avita Medical appoints CEO

    Perry has been a non-executive director for the Cambridge, UK-based regenerative medicine firm since February 2013 and previously served at Novartis in roles such as senior vice president and

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    Bravo has over 25 years of experience in the biopharmaceutical industry, and is a member of the executive committee of the Alliance for Regenerative Medicine (ARM).

  • Liberation Unlimited promotes Danielle Smith Liberation Unlimited promotes Danielle Smith

    She has a BSc in Cellular and Molecular Medicine, specialising in cancer mechanisms, developmental genetics, embryonal cancers, medical virology and regenerative medicine.

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics